How doctors prefer to engage with pharma
It can be via the media, it can be via the internet, it can be via British National Formulary (BNF) license, it can be in the medical press, but information has to be clear, clean, and open to everyone involved – pharmacy, the pharma industry, medical personnel, and the users of the drug – the patients..
"It can be via media, it can be via internet, it can be via BNF license, it can be in the medical press, but information has to be clear, clean, and open..."
That way, when any new drug effect or not known effect (not sure what that means) happened to one of our patients, we knew we should report it to the pharma company that developed the drug, and that effect would be published or broadcast to doctors using it. I like this method of feedback.
If pharma representatives come to see us, we automatically talk about the drug they want to promote, and once we've had the discussion with them we know the effects and side effects, and predicted use, and everything we need to know.
The good old days were when the rep was the only media, and we have since moved to a more digital age, but drug rep remains important.
"In the digital age everything is in front of the screen, but the man behind the machine is still important."
That might take time, but I would welcome a co-relationship between the medical profession and the pharmaceutical industry and would be happy to be involved.